Antidyslipidemic, antiatherogenic and antioxidant activity of allium sativum in charles foster rats

International Journal of Current Pharmaceutical Review and Research

Volumn 2, Issue 2, 2011, Pages 110-119

  Shrivastava, A ^a   Chaturvedi, U ^a   Sonkar, R ^a   Saxena, J K ^a   Khanna, A K ^a   Bhatia, G ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Allium sativum; Antioxidant; Atherosclerosis; Diabetic dyslipidemia; Lipid lowering

Indexed keywords

APOLIPOPROTEIN; GARLIC EXTRACT; HYDROXYL RADICAL; LIPID; NICOTINIC ACID; SUPEROXIDE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIATHEROGENIC ACTIVITY; ANTIDYSLIPIDEMIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DRUG ACTIVITY; DYSLIPIDEMIA; FAT INTAKE; GARLIC; HYPERLIPIDEMIA; IN VIVO STUDY; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLANT BULB; RAT;

EID: 82555185518     PISSN: None     EISSN: 0976822X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Chong PH, Bachenheimer BS (2000) Current, new and future treatments in dyslipidemia and atherosclerosis. Drugs. 60, 55-93.
2. Zalba G, San JG, Morena MU, Fortuna A, Beaumont FJ, Diez J (2001) Oxidative stress in arterial hypertension. Role of NADPH oxidase. Hypertension. 38, 1395-1399.
3. Halliwell B, Gutteridge JMC, Cross CF (1992) Free radicals, antioxidants and human disease: Where are we now? Journal of laboratory and clinical medicine. 119, 598-620.
4. Ballantyne CM (2007) Treatment of dyslipidemia to reduce cardiovascular risk in patients with multiple risk factors. Clin Cornerstone. 8(6), S6-S3.
5. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB (2004) National Heart, Lung and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of Recent Clinical trials for the National Cholesterol Education Program, Adult Treatment Panel III Guidelines. Circulation. 110(2), 227-239.
6. Chattopadhyaya R, Pathak D, Jindal DP (1996) Antihyperlipidemic agents, A review. Indian Drugs. 33, 85-87.
7. Horie T, Murayama T, Mishima T (1989) Protection of liver microsomal membranes from lipid peroxidation by garlic extract. Planta Medica. 55,506-508.
8. Agarwal KC (1996) Therapeutic action of garlic constituents. Medicinal Research Review. 16, 111-124.
9. Koscielny J, Klußendorf D, Latza R, Schmitt R, Radtke H, Siegel G (1999) The antiatherosclerotic effect of Allium sativum. Atherosclerosis. 144, 237-249.
10. Khanna AK, Rizivi F, Chander R (2002) Lipid lowering activity of Phyllanthus niruri in hyperlipidemic rats. J Ethnopharmacol. 82(1), 19-32.
11. Kumar V, Singh S, Khanna AK, Khan MM, Chander R, Mahdi F, Singh R, Singh RK (2008) Hypolipidemic activity of Athenocephalus indicus (Kadam) in hyperlipidemic rats. Med Chem Res. 17, 152-58.
12. Vand Du V, Karr WG (1925) Carbohydrate utilization; rate of disappearance of D-glucose from blood. J Bio Chem. 66, 281-300.
13. Parekh AC, Jung DH (1970) Cholesterol estimation with ferric acetate-uranium acetate and sulfuric acid, ferrous sulfate reagents. Anal Chem. 42,1423-1427.
14. Rice LB (1970) Determination of triglycerides (enzymatic method). Clin Chem. 31(5), 746-750.
15. Kallner A (1975) Determination of phosphate in serum and urine by a single step malachite green method. Clin Chem Acta. 59,35-39.
16. Mosinger F (1965) Photometric adaptation of Doli's micromethod for determination of free fatty acid. J Lipid Res. 6,157-160.
17. Burstein RF, Scholnick VS (1972) Biochemistry and methodology of lipids. J Lipid Res. 25, 375-382.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measured with folin phenol reagent. J Biol Chem. 193, 265-275.
19. Mandukhail SR, Aziz N, Gilani AH (2010) Studies on antidyslipidemic effect of Morinda citrifolia (Noni) fruits, leaves and root extracts. Lipids in Health and Disease. 9, 88-93.
20. Bindoli A, Valente M, Cavallim L (1985) Inhibition of xanthine oxidase and xanthine dehydrogenase activity. Pharmacol Res Commun. 17,831-839.
21. McCord JM, Fridvich I (1969) Superoxide dismutase, an enzyme function for erythrocuprin (hemocuprin). J Biol Chem. 244, 6049-6055.
22. Richmond R, Halliwell R, Chauhan J, Darbre A (1981) Superoxide dependent formation of hydroxyl radicals: detection of hydroxyl radicals by hydroxylation of aromatic compounds. Anal Biochem. 118, 320-35.
23. Halliwell B, Gutteridge JMC, Aroumam OI (1987) The deoxyribose method: a simple test tube assay for determination of rate constants for reaction of OH radicals. Anal Biochem. 165, 2215-2219.
24. Kuroda M, Tanzawa K, Tsujita Y, Endo A (1977) Mechanism for elevation of hepatic cholesterol synthesis and serum cholesterol levels in Triton WR-1339 induced hyperlipidemia. Biochem Biophys Acta. 489(1), 119-125.
25. Schotz MC, Seanu A, Page IH (1957) Effect of triton on lipoprotein lipase of rat plasma. Am J Physiol. 188(2), 399-402.
26. Hayashi T, Ishikawa T, Naito M, Kuzuya M, Funaki C, Asai K, Kuzuya F. (1991) Low level hyperlipidemia impairs endothelium-dependant relaxation of porcin coronary arteries by two mediators. Atherosclerosis. 87(1), 23-28.
27. Nigris F de, Lerman A, Ignarro LJ, Williams-Ignarro S, Sica V, Baker AH, Lerman LO, Geng YJ, Napoli C (2003) Oxidation sensitive mechanisms, vascular apoptosis and atherosclerosis. Trends Mol Med. 9(8), 351-359.
28. Heuman DM, Vlahcevic ZR, Bailey ML, Hylemon PB (1988) Regulation of bile acid synthesis. II Effect of bile acid feeding on enzymes regulating hepatic cholesterol and bile acid synthesis in the rats. Hepatology. 8(4), 892-897.
29. Reusser F (1971) Mode of action of streptozotocin. J Bacteriol. 105(2), 580-588.
30. Al-Shamaony L, Al-Khazraji SM, Twaiji IA Hypoglycemic effect of Artemisia herba alba II. (1994) Effect of valuable extract on some blood parameters in diabetic animals. J Ethnopharmacol. 43, 167-71. IJCPR